Last reviewed · How we verify
combination of various doses of sildenefil and alprostadil
combination of various doses of sildenefil and alprostadil is a Small molecule drug developed by Keogh Institute for Medical Research. It is currently in Phase 1 development.
At a glance
| Generic name | combination of various doses of sildenefil and alprostadil |
|---|---|
| Sponsor | Keogh Institute for Medical Research |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- combination of various doses of sildenefil and alprostadil CI brief — competitive landscape report
- combination of various doses of sildenefil and alprostadil updates RSS · CI watch RSS
- Keogh Institute for Medical Research portfolio CI
Frequently asked questions about combination of various doses of sildenefil and alprostadil
What is combination of various doses of sildenefil and alprostadil?
combination of various doses of sildenefil and alprostadil is a Small molecule drug developed by Keogh Institute for Medical Research.
Who makes combination of various doses of sildenefil and alprostadil?
combination of various doses of sildenefil and alprostadil is developed by Keogh Institute for Medical Research (see full Keogh Institute for Medical Research pipeline at /company/keogh-institute-for-medical-research).
What development phase is combination of various doses of sildenefil and alprostadil in?
combination of various doses of sildenefil and alprostadil is in Phase 1.